Medindia

X

Tanzania: African Malaria Institute Gets $4 Million for Health Research

by Medindia Content Team on  February 23, 2007 at 3:12 PM Tropical Disease News   - G J E 4
Tanzania: African Malaria Institute Gets $4 Million for Health Research
The African Malaria Network Trust (AMANET) has secured a US$4.1million grant to strengthen institutional capacity in health research ethics in Africa (HRE).

The fund will also be used to foster and promote discussion, research and publications that highlight African perspectives.
Advertisement

AMANET's communications officer, Mr. Charles Wanga told Business Week in Dar es Salaam last week that the grant secured from the Bill and Melinda Gates Foundation would focus on HRE review process across the sub-Saharan Africa, particularly in institutions undertaking malaria intervention trials.

Advertisement
Wanga said that worsening malaria situation in sub-Saharan Africa, unprecedented progress and promise from biomedical research discoveries; and the need to bridge the malaria funding gap was the motivation behind the fund.

"Consequently, more malaria research and trials involving African and non-African scientists and institutions will have to be undertaken in Africa," he said.

Source: Bio-Bio Technology
SRM
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
“A Chinese Native Medicinal mixture of Treating Malaria” The medicinal invention patent is to be transferred. So far , the first choice medicine of treating malaria is the blue wormwood element (artemisinin). It’s effective to treat malaria, but the blue wormwood mostly grows in Chinese and Vietnam’s plateau area . It’s mining cost is high. The global output is difficult to satisfy the market dement every year. And the treatment time is long. The expense is high. The goal of this invention lies in providing a new , most advanced medicine of treating malaria in the present world. Its treatment course is short (in 1-3 days) and it cures completely. Its expense is low(5-15 yuan) and it has no sid eeffect. tion and the market economic benefit have the potential of monopolizing the global ! Contact:Chonglin Tu Mail box: com001018@163.com
guest Wednesday, May 23, 2007

You May Also Like

Advertisement
View All